Prevention Kit

Supplier: Covid 19, pandemics, and infection prevention consumer products such as ipc infection prevention kit for patients, ipc infection prevention kit for children, ipc infection prevention kit for the workplace, antimicrobial rambo ffp3 mask, antimicrobial rambo germ free sticker tape, antimicrobial rambo germ free lift button stickers, antimicrobial rambo mask spray anti fungal, antimicrobial rambo 30 day disin spray, antimicrobial disintact air disinfectant, antimicrobial all food disin wash, antimicrobial rambo door handle sleeves, antimicrobial rambo all purpose handle covers, antimicrobial rambo handkerchief, antimicrobial rambo pillowcases, antimicrobial rambo pillowcase

The COVID-19 RT-PCR Detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, 42 U.S.C. 263a, to perform high complexity tests. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infective status. The agent detected may not be the definite cause of disease. Positive results do not rule out bacterial co-infection with other viruses. Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The COVID-19 RT-PCR Detection Kit is intended for use by qualified trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures. The COVID-19 RT-PCR Detection Kit is only for use under the Food and Drug Administration's Emergency Use Authorization. PRINCIPLE OF DETECTION This product is a fluorescent probe-based Taqman RT-PCR assay system. Firstly, the RNA of SARS-CoV-2 will be reverse transcribed into cDNA by reverse transcriptase, and then PCR amplification will be performed with cDNA as template. During amplification of the template, the TaqMan probe will be degraded due to the 5'-3 polymerase activity and exonuclease activity of Taq DNA polymerase, then the separation of fluorescent reporter and quencher enables the fluorescent signal to be detected by instrument. The ORF1ab gene of SARS-CoV-2 will be detected qualitatively by FAM channel, the N gene of SARS-CoV-2 will be detected qualitatively by JOE channel, the E gene of SARS-CoV-2 will be detected qualitatively by ROX channel, and the internal reference will be detected by CY5 channel. dUTP and UNG enzyme are used in the kit to prevent contamination of the amplified products. Internal reference is used in the kit for quality control starting from sample collection

Cov-inu RT-PCR kit is a probe based Real Time PCR test designed for the qualitative de- tection of SARS-CoV-2 Coronavirus, the etiological agent of COVID-2019 and A + B Group Inuenza virus (orthomyxovirus). It is used to detect S- M2 ve NS1 genes in viral RNA. Description of the Kit Cov-inu RT PCR Kit is a multiplex PCR kit that is used for the simultaneous detection of COVID-19 agent SARS-COV-2 and Inuenza A and Inuenza B viruses from the same sample. Coronaviruses are a large family of viruses that cause infections in humans and other mammals (such as camels, cats, dogs, and bats). The SARS-CoV-2 virus is a new coronavirus that was identified by the World Health Organization (WHO) (1) on February 11, 2020. Inuenza is caused by three types of immunological RNA viruses (A, B and C) in the Orthomyxoviridae family. Seasonal inuenza is typically caused by three main hem- agglutinin subtypes (H1, H2, and H3) and two neuraminidase subtypes (N1 and N2). It is important that public health laboratories around the world conduct detailed surveillance to monitor the spread and impact of the pandemic H1N1 2009 virus, as well as predict future changes in virulence (4). Therefore, methods for rapid diagnosis, case detection and follow-up of this new pathogen in the human population are necessary to develop appropriate management strategies to reduce morbidity and mortality. The test works with single-stage real time reverse transcriptase polymerase chain reaction (On- eStep RT-PCR) with serum, lower respiratory tract samples (e.g. bronchoalveolar lavage, sputum, tracheal aspirate), and upper respiratory tract samples (e.g. nasopharyngeal uids, nasal swab) from individuals who demonstrate clinical criteria set for COVID-19 by WHO (2) and CDC (Center for Disease Control and Prevention) (3). This kit is an In-vitro diagnostic kit using specific primers designed for qualitative detection of genomic RNAs of SARS-CoV-2, Inuenza A and Inuenza B virus.

Serachem India Private Ltd. have been successfully able to develop a transport media for CORONA virus by deactivating it. This means, now we don't have to be at risk while transporting the samples for testing to lab. Also, at present, as per the laid guidelines of ICMR Corona Virus testing can only be done in Biosafe Level-III laboratories. Which are very limited in no. Reason for the same is due to high level of security required in handling the virus. But now when we use STM Viral Transport Medium and Total Nucleic Acid Preservation System provides a rapid and simple method for the collection, preservation and shipping of swab samples in place of VTM (Viral Transport Medium) handling of the virus will be very safe and tests can now be conducted by any testing lab without posing a spread risk. This breakthrough will help in stopping the possible outbreak inside testing labs and hospitals and prevent a bigger disaster. Advantages of STM Viral Transport Medium: 1. No threat of exposure to live virus. 2. The Swab Preservative not only inactivates viruses but also prevents the growth of Gram-negative and Gram-positive bacteria and fungi allowing the resulting non-infectious samples to be handled and shipped safely. 3. The sample can be transported and preserved at room temperature for up to 3 days. (The sample does not get spoiled). 4. No need of having Biosafe Level -III safety norms in labs. 5. No chance of spreading of the virus in labs. 6. Safe for the institutions and their lab staff and medical staffs. 7. Testing facility can be increased exponentially. 8. More sample collection centres can be developed which will help in developing post outbreak strategies. 9. It has also been approved by ICMR. 10. Comes with two sterile Polyester Swabs with visible break point. 11. Price is almost same as VTM Kit. Two separately packed sterile synthetic fibre NYLON swabs with break point. 10-15 ml volume screw-cap, leak-proof self-standing tubes containing 2-3 ml viral transport medium (VTM) Vial has labeling stickers ï?? The pH is 7.3+ 0.3 and the osmolality in mOsm/Kg H20 500.00-600.00 The medium is stable at room temperature. STM meets European CE-IVD / US-FDA approved. Approved by ICMR.

The new crown virus has broken the otherwise peaceful life and messed up people's lives. It is because of the extremely high risk of infection that everyone is afraid and cautious. When difficulties arise, methods to solve them will follow. In order to determine whether they are infected with the new crown virus, nucleic acid testing has made its debut. Nucleic acid testing is an important means to confirm the new coronavirus, and it is also one of the important processes for patients to confirm the diagnosis. To do nucleic acid testing, Nucleic acid detection has the characteristics of early diagnosis, high sensitivity and specificity, and is the "gold standard" for diagnosing new coronary pneumonia. Currently, the most widely used real-time fluorescent quantitative RT-PCR technology. Generally, the two targets located on the ORF1ab and N genes of the virus are detected. The same specimen must meet the double target positive or the repeated test as single target positive, or the two specimens must meet the single target at the same time to confirm the positive of SARS-CoV-2 virus nucleic acid. The virus transport medium developed by Desheng for the new coronavirus is inactivated and non-inactivated. The nucleic acid detection mainly uses an inactivated virus transport medium, which can instantly crack the pathogen and release the nucleic acid, and the protective agent can prevent the nucleic acid from being degraded. . By fully mixing the collected sample with the virus lysis solution and the virus nucleic acid preservation solution, the virus in the sample can be inactivated. Colleagues can effectively ensure the integrity of the virus nucleic acid in the sample. The collected sample can be transported and processed under normal temperature conditions. Long-term preservation. The saved viral RNA samples can be widely used in genetic testing, enzyme-linked immunoassay (ELISA), PCR testing, etc. Although Desheng does not currently have the technology to produce nucleic acid detection kits, it can produce virus preservation solutions, disposable virus sampling tubes and biological buffers required for nucleic acid detection, as well as luminol and acridine as the raw materials for antigen and antibody detection. ester. Desheng is willing to contribute its part in the fight against the epidemic, and is willing to fight for the cause of human health.

STANDARD M nCoV Real-Time Detection kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. Coronavirus RNA was first transcribed into cDNA by reverse transcriptase, and then cDNA was used as a template for PCR amplification. The separation of the fluorophore and quencher makes the fluorescence signal detected by the instrument: FAM channel qualitative detection of the new coronavirus (COVID-19) ORF1ab gene, and JOE channel qualitative detection of coronavirus) E gene, and CY5 channel detection internal reference. The kit uses dUTP and UNG enzymes to prevent contamination of amplification products.

Bacterial Vaginosis Quick Test Kit is designed as a simple, rapid, cost effective method for in vitro testing. It is qualitative test for the determination of neuraminidase (SNa) in female vaginal fluid, which is auxiliary diagnosis of bacterial vaginosis. Application Used to assist the diagnostic of bacterial vaginosis, evaluate the micro ecological balance in genital tract, and to prevent recurrences of vaginosis. Advantage High sensitivity, strong specificity Easy operation, convenient and effective No need of special instrument, no need of professional training

CE Approved The Follicle Stimulating Hormone (FSH) Test Kit is a rapid qualitative test for detect FSH in urine. This help to check the function of the pituitary gland and check if hormone levels are normal. The test can be used to see if a woman has started the menopause. The test may also be used (along with other tests) for detecting possible causes of both male and female infertility. Self-detection of ovarian function Guide to prevention of premature ovarian Diagnosis of menopause

The outbreak of the novel coronavirus (COVID-19) rapidly transmit all over China and lots of countries. Although molecular test (RT-PCR) has become the standard method for diagnosis of this disease, the method has many limitations. In addition, the high false negative rates were reported. There is an urgent need for an accurate and rapid testing method that quickly identify large number of infected patients and asymptomatic carriers to prevent virus transmission and assure timely treatment of patients. GenBody COVID-19 IgM/IgG device is a chromatographic immunoassay kit for the rapid and differential detection of immunoglobulin M (lgM) and immunoglobulin G (IgG) against COVID-19 using serum, plasma and whole blood.